BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33360835)

  • 41. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
    Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity-dependent SUMOylation of the brain-specific scaffolding protein GISP.
    Kantamneni S; Wilkinson KA; Jaafari N; Ashikaga E; Rocca D; Rubin P; Jacobs SC; Nishimune A; Henley JM
    Biochem Biophys Res Commun; 2011 Jun; 409(4):657-62. PubMed ID: 21616059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
    Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
    Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ca
    Scott MB; Kammermeier PJ
    Channels (Austin); 2017 Nov; 11(6):555-573. PubMed ID: 28837380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. UBC9 regulates cardiac sodium channel Na
    Tang B; Hu Y; Wang Z; Cheng C; Wang P; Liang L; Xiong H; Luo C; Xu C; Chen Q; Wang QK
    J Mol Cell Cardiol; 2019 Apr; 129():79-91. PubMed ID: 30772377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
    Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
    J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of synaptic transmission and G protein modulation by synthetic CaV2.2 Ca²+ channel peptides.
    Bucci G; Mochida S; Stephens GJ
    J Physiol; 2011 Jul; 589(Pt 13):3085-101. PubMed ID: 21521766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gap junction channel protein connexin 43 is covalently modified and regulated by SUMOylation.
    Kjenseth A; Fykerud TA; Sirnes S; Bruun J; Yohannes Z; Kolberg M; Omori Y; Rivedal E; Leithe E
    J Biol Chem; 2012 May; 287(19):15851-61. PubMed ID: 22411987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mutation in Ca
    Tyagi S; Bendrick TR; Filipova D; Papadopoulos S; Bannister RA
    J Gen Physiol; 2019 Jun; 151(6):850-859. PubMed ID: 31015257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation.
    Belaguli NS; Zhang M; Brunicardi FC; Berger DH
    PLoS One; 2012; 7(10):e48019. PubMed ID: 23118920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cav2.1 channels control multivesicular release by relying on their distance from exocytotic Ca2+ sensors at rat cerebellar granule cells.
    Satake S; Imoto K
    J Neurosci; 2014 Jan; 34(4):1462-74. PubMed ID: 24453334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
    Sáez JE; Arredondo C; Rivera C; Andrés ME
    Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
    François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
    Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.